Galleri Blood Test Cuts Late-Stage Cancer by 26%

GRAIL's NHS-Galleri trial results are in, and they show a promising reduction in Stage IV cancer diagnoses by using the Galleri blood test. Over three years, the test helped catch cancers earlier, lowering Stage IV diagnoses by up to 26% in the later rounds of screening. It's a big win for early detection, though the main goal of reducing combined late-stage cancer diagnoses wasn't met. What does it mean for you? Catching cancer early can make a huge difference, and with tests like Galleri, there's hope for more effective treatments and better outcomes. If you're over 50, this could mean more proactive screening options in the future.

Original source Read the full story →
More from this briefing
Consumer Confidence Dips Amid Global Price Pressures China and Kyrgyzstan Unite in Photo Exhibit EU AI Rules Fall Short in Global Impact Cyient Expands AI Prowess with TAO Digital Acquisition PAPZIMEOS: Breakthrough Treatment for Respiratory Papillomatosis New Cancer Hope: Whitehawk Targets SEZ6 Protein CollPlant Explores New Frontiers in Dermal Fillers Legal Titans Shine at Women in Business Law Awards Chemical Leak Prompts Mass Evacuation in California Investors Alert: Join Immutep Class Action Now

Get stories like this every morning.

Five-minute intelligence briefing — in your inbox at 6 AM.

Subscribe now